Drug Database
Back to search

Switzerland· 57699001

Pyrazinamide Labatec 400 mg, comprimés

A pyrazinamide product containing pyrazinamidum, registered in Switzerland by Labatec Pharma SA and dispensed under Swissmedic category A. The same ATC class is registered in 14 of our 19 countries.

Cat A (Swissmedic)ATC J04AK01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPyrazinamide Labatec 400 mg, comprimésATCJ04AK01REGISTER NO.57699001PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pyrazinamidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pyrazinamide is registered in 14 of 19 countries.

Countries holding a registration under ATC J04AK01 (pyrazinamide), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search pyrazinamide products by name

Pyrazinamide · ATC J04AK01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyrazinamide costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.61 in France to $3.20 in Switzerland — a ×5.2 gap.

  • Switzerland: $3.20 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pyrazinamide · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.20
  • FR France$0.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
pyrazinamidum
Manufacturer
Labatec Pharma SA
Country
Switzerland (CH)
ATC code
J04AK01
ATC class
Pyrazinamide
Defined daily dose
1.5 g, O
Swissmedic category
A
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for pyrazinamide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pyrazinamide against other medicinesHow interaction checks work

Pyrazinamide · interactions on record

81 records

  • 4 severe
  • 19 moderate
  • 54 info

Most severe, free to view

  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • TeriflunomideL04AK02severe

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyrazinamide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyrazinamide products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Pyrafat
  • Belgium · Tebrazid
  • Bulgaria · Пиразинамид Крка
  • Germany · Pyrafat, Pyrazinamid Jenapharm
  • Denmark · Pyrazinamid Sad
  • Spain · Pirazinamida Prodes
  • Finland · Tisamid
  • France · Pirilene
  • United Kingdom (Northern Ireland) · Pyrazinamide Morningside Healthcare
  • Greece · Pyrazinamide Genepharm
  • Croatia · Pyrazinamid Krka
  • Lithuania · Pyrafat, Pyrazinamide Krka
  • Luxembourg · Tebrazid
  • Latvia · Pyrazinamide Olpha
  • Malta · Pyrazinamide Morningside Healthcare
  • Netherlands · Pyrazinamide Cf
  • Poland · Pyrazinamid Farmapol
  • Portugal · Pramide
  • Romania · Pirazinamida Atb
  • Slovenia · Pirazinamid Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/79270494-1f2f-4ced-8fbc-c10e3522b742
GET /v1/drugs/79270494-1f2f-4ced-8fbc-c10e3522b742?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about pyrazinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console